Annual Report • Jun 5, 2018
Annual Report
Open in ViewerOpens in native device viewer
| ATHENS MEDICAL CENTER S.A. | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 5-7 Distomou Str, 15125 Maroussi | REG. No. 13782/06/Β/86/06 General Commercial Registry : 356301000 | |||||||||
| FINANCIAL STATEMENT AND INFORMATION FOR THE YEAR 1 January 2017 until 31 December 2017 (In accordance to L.2190/20, article 135 for companies that prepare annual financial statements, consolidated and not, according to IFRS) |
||||||||||
| The following results and information, that arise from the company's financial statements, provide a general picture of the financial position and financial results of the ATHENS MEDICAL CENTER S.A. (Issuer) and the Group. Thus we suggest the reader, before entering into any sort of investment decision or other transaction with the company to gain access to the | ||||||||||
| company's web site, where the financial statements can be downloaded, as well as the Auditor's Certificate. | ||||||||||
| Prefecture: | Ministry of Development and Competitiveness - | Company's Board of Directors | ||||||||
| Company's web site: | Department for Limited Companies www.iatriko.gr |
Name | Position | |||||||
| Date of approval by the Board of Directors of the annual Financial Statements : |
30 April 2018 | Dr. George V. Apostolopoulos Dr. Vassilios G. Apostolopoulos |
President CEO |
|||||||
| Certified Auditor Accountant : | Panagiotis Bountros Certified Auditor Accountant AM SOEL 22011 | Christos G. Apostolopoulos | Vice President | |||||||
| Auditing Company : Type of Auditor's Certificate : |
KPMG Certified Auditors A.E. SOEL 114 Unqualified opinion |
Dr. Jan Liersch Ruediger Nikolaos Koritsas |
Member (non executive) Member (Independent non executive) |
|||||||
| Mikroulea Alexandra | Member (Independent non executive) | |||||||||
| Vassilios Tountopoulos | Member (Independent non executive) | |||||||||
| STATEMENT OF FINANCIAL POSITION (annual consolidated and non consolidated) amounts in € | GROUP | PARENT | CASH FLOW STATEMENT FOR THE YEAR (annual consolidated and non consolidated) amounts in € Indirect method |
GROUP | PARENT | |||||
| ASSETS | 31/12/2017 | 31/12/2016 | 31/12/2017 | 31/12/2016 | 1/1-31/12/2017 | 1/1-31/12/2016 | 1/1-31/12/2017 | 1/1-31/12/2016 | ||
| Property, plant and equipment | 224.389.369,67 | 228.251.704,84 | 212.344.372,87 | 216.436.433,35 Operating Activities : Profit / (Loss) before taxes (continued operations) |
5.797.430,33 | 6.761.234,24 | 4.031.348,18 | 3.336.089,52 | ||
| Intangible assets Other non current assets |
437.184,48 7.949.577,21 |
339.236,20 10.721.483,97 |
425.682,83 27.990.912,29 |
335.020,13 | 30.659.359,75 Plus/Less adjustments for : | |||||
| Inventory | 4.535.178,84 | 4.476.918,19 | 4.370.419,81 | 4.210.747,96 Depreciation | 9.407.527,96 | 8.210.729,40 | 9.221.035,63 | 8.021.298,68 | ||
| Receivables (trade debtors) Other current assets |
84.339.283,19 39.808.267,77 |
83.703.511,78 41.169.609,08 |
84.170.856,89 41.864.271,05 |
41.925.254,76 Provisions | 83.258.499,81 Impairment of tangible and intangible fixed assets | 1.881.343,58 | 0,00 2.512.912,58 |
0,00 0,00 1.623.463,00 |
0,00 2.524.511,24 |
|
| Exchange differences | -2.679,00 | -365,00 0,00 |
0,00 | |||||||
| TOTAL ASSETS EQUITY AND LIABILITIES |
361.458.861,16 | 368.662.464,06 | 371.166.515,74 | 376.825.315,76 Results (revenue, expenses, gains and losses) from investing activities |
159.001,61 | -16.003,06 103.538,94 |
-38.032,48 | |||
| Share capital | 26.888.153,80 | 26.888.153,80 | 26.888.153,80 | 26.888.153,80 Interest expenses and related costs | 8.159.772,48 | 8.494.610,80 | 7.878.934,42 | 10.802.986,18 | ||
| Other components of equity Total equity attributable to owners of the parent (a) |
36.291.931,04 63.180.084,84 |
33.766.075,40 60.654.229,20 |
38.277.227,53 65.165.381,33 |
36.857.513,92 Plus/Less adjustments for changes in 63.745.667,72 working capital or related to operating |
||||||
| Non controlling interests (b) | 161.453,93 | 103.075,48 | activities : | |||||||
| Total Equity (c) = (a)+(b) Long term borrowings |
63.341.538,77 203.078,01 |
60.757.304,68 11.161,70 |
65.165.381,33 0,00 |
63.745.667,72 Decrease / (Increase) in inventories 4.787,68 Decrease / (Increase) in receivables |
-9.952.795,74 | -58.260,65 208.030,78 -5.790.179,12 |
-159.671,85 -11.619.687,60 |
276.664,08 -3.966.426,59 |
||
| Long term provisions / Non current liabilities | 40.544.321,37 | 41.594.875,95 | 40.432.007,90 | 41.489.563,75 (Decrease) / Increase in liabilities (except for borrowings) | -8.013.277,51 | -1.985.671,50 | -4.451.382,65 | -593.778,33 | ||
| Short term borrowings Other current liabilities |
143.129.348,83 114.240.574,18 |
144.880.368,27 121.418.753,46 |
140.813.592,90 124.755.533,61 |
142.580.817,25 Less : | 129.004.479,36 Interest charges and related expenses paid | -8.439.478,25 | -8.346.188,37 | -8.209.379,15 | -8.186.375,34 | |
| Paid taxes | -465.792,03 -273.735,25 |
-115.828,13 | -145.484,33 | |||||||
| Total liabilities (d) | 298.117.322,39 | 307.905.159,38 | 306.001.134,41 | 313.079.648,04 Total Inflows / (Outflows) from | ||||||
| TOTAL EQUITY AND LIABILITIES (c)+(d) | STATEMENT OF CHANGES IN EQUITY FOR THE YEAR (annual consolidated and non consolidated) amounts in € | 361.458.861,16 | 368.662.464,06 | 371.166.515,74 | 376.825.315,76 Operating Activities (a) Investing Activities |
-1.527.207,22 | 9.775.375,50 | -1.697.629,21 | 12.031.452,63 | |
| GROUP | PARENT | |||||||||
| Total equity in the beginning of the year | 31/12/2017 | 31/12/2016 | 31/12/2017 | 31/12/2016 | Purchase of tangible and intangible fixed assets | -5.833.291,68 | -3.767.663,64 | -5.388.028,21 | -3.608.468,73 | |
| (1/1/2017 and 1/1/2016 accordingly) | 60.757.304,68 | 58.846.732,31 | 63.745.667,72 | 64.845.502,94 Cash collection from the sale of tangible and intangible | ||||||
| Total comprehensive income after taxes | fixed assets Cash flows (inflows) from the sale (aquisistion) of investments (shares, securities) |
5.201,00 0,00 |
8.458,73 1.301,00 0,00 0,00 |
8.158,73 -2.470.000,00 |
||||||
| (continued and discontinued operations) | 2.584.234,09 | 1.972.872,44 | 1.419.713,61 | -1.099.835,22 Income from interest | 3.188,47 | 4.411,28 2.820,97 |
3.680,65 | |||
| Dividend distributed | 0,00 | -62.300,07 | 0,00 | 0,00 | Income from dividend | 0,00 | 0,00 0,00 |
30.685,11 | ||
| Total Inflows / (Outflows) from | ||||||||||
| Total equity at the end of the year (31/12/2017 and 31/12/2016 accordingly) |
63.341.538,77 | 60.757.304,68 | 65.165.381,33 | Investing Activities (b) 63.745.667,72 Financing Activities |
-5.824.902,21 | -3.754.793,63 | -5.383.906,24 | -6.035.944,24 | ||
| Receipts from borrowings | 526.795,06 1.191.868,65 |
212.215,06 | 1.191.868,65 | |||||||
| Debt repayment Payments of financial leasing |
-1.963.628,16 | -5.361.028,71 | -1.962.743,08 | -5.361.028,71 | ||||||
| (Capital installments) | -110.270,00 | -60.062,00 -11.484,00 |
-11.484,00 | |||||||
| Dividend paid | -55.173,46 | -35.370,01 0,00 |
0,00 | |||||||
| Total Inflows / (Outflows) from | ||||||||||
| Financing Activities ( c) Net Increase / (Decrease) in Cash and Cash Equivalents |
-1.602.276,56 | -4.264.592,07 | -1.762.012,02 | -4.180.644,06 | ||||||
| for the year (a)+(b)+( c) Cash and Cash Equivalents (beginning) |
-8.954.385,99 12.182.274,97 |
1.755.989,80 10.426.285,17 |
-8.843.547,47 11.715.914,86 |
1.814.864,33 9.901.050,53 |
||||||
| Cash and Cash Equivalents (year end) | 3.227.888,98 | 12.182.274,97 | 2.872.367,39 | 11.715.914,86 | ||||||
| STATEMENT OF COMPREHENSIVE INCOME (annual consolidated and non consolidated) amounts in € | ||||||||||
| GROUP | PARENT | |||||||||
| 1/1-31/12/2017 | 1/1-31/12/2016 | 1/1-31/12/2017 | 1/1-31/12/2016 | |||||||
| Turnover Gross profit / (loss) |
169.266.755,48 36.696.341,59 |
167.346.104,73 37.290.615,69 |
164.028.115,88 32.838.080,66 |
162.676.475,07 34.761.336,78 |
||||||
| Profit / (Loss) before taxes, financing and | ||||||||||
| investing activity Profit / (Loss) before taxes |
14.116.204,42 5.797.430,33 |
15.239.841,98 6.761.234,24 |
12.013.821,54 4.031.348,18 |
14.101.043,22 3.336.089,52 |
||||||
| Profit / (Loss) after taxes (A) | 2.686.184,66 | 3.527.874,78 | 1.495.242,17 | 445.479,86 | ||||||
| Attributable to: Owners of the parent |
2.626.572,56 | 3.468.871,42 | 1.495.242,17 | 445.479,86 | ||||||
| Non controlling interests | 59.612,09 | 59.003,36 | ||||||||
| Other comprehensive income after taxes (B) Total comprehensive income after taxes (A)+(B) |
-101.950,56 2.584.234,10 |
-1.555.002,34 1.972.872,44 |
-75.528,56 1.419.713,61 |
-1.545.315,08 -1.099.835,22 |
||||||
| Attributable to: | ||||||||||
| Owners of the parent Non controlling interests |
2.525.855,64 58.378,45 |
1.915.533,00 57.339,44 |
1.419.713,61 | -1.099.835,22 | ||||||
| Earnings (after taxes) per share - basic in € | 0,0303 | 0,0400 | 0,0172 | 0,0051 | ||||||
| Proposed dividend per share - in € Profit / (Loss) before taxes, financing and |
0,0000 | 0,0000 | ||||||||
| investing activity and depreciation | 23.523.732,38 | 23.450.571,38 ADDITIONAL INFORMATION : |
21.234.857,17 | 22.122.341,90 | ||||||
| Group Structure | Participation | Consolidation | Tax Unaudited | 8. Disclosures of transactions with related parties of group and company as defined in IAS 24 (amounts in €) : | ||||||
| Companies | Residence | (%) | Method | Years | GROUP PARENT |
|||||
| ATHENS MEDICAL CENTER SA IATRIKI TECHNIKI SA |
Maroussi Attica Kiffisia Attica |
Parent Co 100,00 |
TOTAL | -- -- |
a) Revenue b) Expenses |
0,00 437.845,13 13.045.212,18 |
182.187,25 | |||
| AKSONIKI EREVNA SA EREVNA SA |
Maroussi Attica Maroussi Attica |
50,50 51,00 |
TOTAL TOTAL |
2007-2017 2007-2017 |
c) Receivables d) Liabilities |
324.376,39 5.194.365,19 56.262,42 38.611.978,14 |
||||
| PHYSIOTHERAPY | e) Transactions and compensations of executives | |||||||||
| CENTER SA HOSPITAL AFFILIATES INTERNATIONAL SA |
Maroussi Attica Kiffisia Attica |
33,00 68,89 |
TOTAL TOTAL |
-- 2007-2010 & 2012 - 2017 |
and members of the Board f) Receivables from executives |
3.586.812,46 3.116.984,18 |
||||
| MEDSANA BMC | Bucharest Romania | 100,00 | TOTAL | -- | and members of the Board | |||||
| BIOAXIS SRL (former MEDSANA SRL) | Bucharest Romania | 78,90 | TOTAL | -- | g) Liabilities to executives and members of the Board |
851.955,44 | 681.794,65 | |||
| e) Other related party transactions | 613.260,43 | 613.260,43 | ||||||||
| EUROSITE SA GAIA SA |
Maroussi Attica Athens |
100,00 100,00 |
TOTAL TOTAL |
2014 - 2017 2015 - 2017 |
9. The amounts of formed provisions are the following (amounts in €): | GROUP PARENT |
||||
| a) Legal disputes | 207.776,96 | 0,00 | ||||||||
| b) Tax unaudited years c) Other provisions |
0,00 0,00 |
0,00 0,00 |
||||||||
| 10. The amount of other comprehensive income after taxes of group for year 1/1-31/12/2017 € -102 th includes exchange differences expense amounted to € -24 th, | ||||||||||
| 1. All companies in the group are those described in the above table titled "Group Structure". There is no deviation in the companies and the method of consolidation relative to | deferred tax income amounted to € 31 th, recognized actuarial losses amounted to € -109 th. The respective amount € -1.555 th for year 1/1-31/12/2016 includes exchange differences expense amounted to € -3 th, deferred tax income amounted to € 634 th, recognized actuarial losses amounted to € -2.186 th. The amount of |
|||||||||
| that used in the financial statements of the previous year 2016 except the case of INTEROPTICS SA, which was sold in March 2017. The effect due to the sale in profit/(loss) after | other comprehensive income after taxes of company for year 1/1-31/12/2017 € -76 th, includes deferred tax income amounted to € 31 th, recognized actuarial losses € | |||||||||
| taxes and non controlling interests as well as in equity attributtable to owners of the parent is of no significance, while there is no effect in turnover. A detailed report is found in note 22 of annual financial statements. |
-107 th. The respective amount € -1.545 th th for year 1/1-31/12/2016 includes deferred tax income amounted to € 631 th, recognized actuarial losses € -2.176 th | |||||||||
| 11. A detailed report to group's structure is found in paragraphs 1 "General information about Company and Group", 6a "Accounting Policies ", as well as in | ||||||||||
| 2. The full Audit report of the independent auditor is included in the Annual Financial Statements. | paragraphs 21 "Investments in Subsidiaries" and 22 " Equity accounted investees " of the Annual Financial Report. 12. The accounting policies, applied by the Group and the Company for the completion of the annual Financial Statements as at 31/12/2017, are consistent with those |
|||||||||
| 3. There are pledges against the group's land and buildings, which refer to mortgage attachment amounted to 354 mil. | stated in the Financial Statements as at 31/12/2016. | |||||||||
| 13. In October of closing year 2017 the restructuring of the 12/7/2012 common Bond Loan was concluded, which was reclassified as current due to the non | ||||||||||
| 4. There are no legal disputes against Company that could have a significant effect on the company's and the group's financial structure. | compliance to terms included in the relevant amendment of the common Bond Loan issuance programm . A detailed report is found in note 29 of annual financial statements. |
|||||||||
| 5. The total number of employees for year 2017 was: group 2.940 (2.861 for year 2016) and parent co 2.804 (2.710 for year 2016) respectively. | ||||||||||
| 6. Profit/(losses) per share was calculated using the average weighted number of total shares issued. | ||||||||||
| 7. At 31/12/2017 no treasury shares were held by parent company, nor its subsidiaries. | ||||||||||
| Maroussi, 30 April 2018 | ||||||||||
| The President of the BoD | The CEO | The General Group CFO | The Parent CFO | The Parent Chief Accountant | ||||||
| and member of the BoD | ||||||||||
| Georgios V. Apostolopoulos | Vassilios G. Apostolopoulos | Emmanouil P. Markopoulos | Petros D. Adamopoulos | Panagiotis Ch. Katsihtis |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.